Latest Michael Kauffman Stories
EMERYVILLE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has appointed Ted W. Love, M.D., Executive Vice President and Head of Research and Development.
Epix Pharmaceuticals has announced that Michael Kauffman has resigned his position as CEO and director, to pursue other opportunities. Mr Kauffman joined Epix in August 2006 in connection with its acquisition of Predix Pharmaceuticals Holdings, where he had served as CEO since September 2002.
- totally perplexed and mixed up.